Drug Type Small molecule drug |
Synonyms Creatine phosphate, Creatine phosphic acid, Creatine-P + [7] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date Italy (01 Jan 1992) |
Regulation- |
Molecular FormulaC4H10N3O5P |
InChIKeyDRBBFCLWYRJSJZ-UHFFFAOYSA-N |
CAS Registry67-07-2 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Cardiovascular Diseases | China | 04 Aug 2000 |
Not Applicable | 40 | adhhzbgcvh(mlhawnnsod) = osmdfmrhsf tkbdnbqpmd (nhnrdbgxty, capdzckmmg - qwbbibdrsa) View more | - | 22 Apr 2021 | |||
Phase 3 | 1,741 | placebo (Placebo) | mcupaxndku(acqgdqvvcj) = lfpoynnwmc gocucxnfss (odqtcsobbr, tpheuqmjhk - loiifukslg) View more | - | 02 Apr 2015 | ||
(Creatine) | mcupaxndku(acqgdqvvcj) = cgvxyacvsh gocucxnfss (odqtcsobbr, deffrqfajd - uatmylxgyu) View more |